What Seamaty does

Seamaty (斯马特) is a Chengdu-based POCT (Point-of-Care Testing) medical device manufacturer founded in August 2012 that designs, produces, and markets both instruments and proprietary reagent consumables for human medical diagnostics and veterinary use. Its core technology is built around microfluidic reagent discs integrated with dry biochemical analysis, capillary chemiluminescence, and blood gas electrolyte platforms, with five major product lines spanning microfluidic biochemistry, blood gas electrolyte, chemiluminescence immunoassay, blood cell analysis, and PCR molecular detection. The company sells flagship instruments such as the SD1 and SD2 dry biochemical analyzers, SMT-120VP/SMT-120Pro veterinary biochemical analyzers, SG1 blood gas electrolyte analyzer, VG2 blood gas immunoanalyzer, MiniLabVet four-channel analyzer, and VQ1 PCR system, paired with proprietary reagent discs containing 39-40 test items in multiple panel combinations.

The company's commercial model is a hybrid of direct sales through 10 wholly-owned subsidiaries (2 domestic in Chengdu and Shenzhen, 8 overseas in Germany, Thailand, Russia, Brazil, Singapore, Turkey, and Egypt) plus authorized domestic dealer/distributor networks covering 23 provinces and 283 cities in China. Revenue is generated primarily through hardware sales and high-margin recurring reagent disc consumables, with export channels contributing approximately 55% of total revenue and products distributed across 150+ countries; the company claims 40% share of China's veterinary clinics and pet hospitals. R&D intensity is approximately 13.6% of revenue with 20%+ of the 700+ global workforce in R&D roles, and the business holds 130+ patents including 7 international authorized invention patents and 2 PCT patents. In January 2024, Seamaty converted from a limited liability company to a joint-stock company as part of preparation for a potential public listing, and it is currently building an 82-mu, 130,000 sqm POCT manufacturing base in Chengdu Eastern New Area to scale capacity to 50,000 instruments and 60 million reagent consumables annually.

Name

Seamaty

Legal name

成都斯马特科技股份有限公司

Website

https://cn.seamaty.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

51–100 employees

Short description

Seamaty is a Chengdu-based POCT medical device manufacturer developing microfluidic biochemical analyzers, blood gas, chemiluminescence, and PCR systems paired with proprietary reagent discs, serving veterinary clinics, pet hospitals, and primary healthcare institutions across 150+ countries with 40% domestic veterinary market share.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostic Medical Devices (POCT)

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Veterinary POCT & Rapid Diagnostics (Animal health rapid tests) (HLAHAOAL)

akta.pro secondary industries

Point-of-Care Testing (POCT) & Near-Patient Labs (HLAFAMAI), Molecular POCT / NAAT Systems (PCR/Isothermal platforms & cartridges) (HLAHAOAI), Practice Consumables & General Medical Supplies (Needles, Syringes, Gloves, Swabs) (HLAMAFAO)

Keywords

• Point-of-care testing
• Veterinary diagnostic analyzers
• Microfluidic biochemical analyzers
• In-vitro diagnostic reagents
• Blood gas electrolyte analyzers

Headquarters

HQ city

Guangming

HQ country

China

HQ region

Asia

Offices10 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

1. POCT Medical Equipment Sales: Sale of biochemical analyzers including SD1, SMT-120VP, SMT-120Pro, SD2, and related instruments for veterinary and human medical diagnostic use.
2. Reagent Discs and Consumables: Single-use reagent discs with integrated freeze-dried reagents for various biochemical tests. Available in 24 combinations for human medical and 13 combinations for veterinary use.
3. International Export: Export sales account for approximately 55% of total revenue, with products sold to over 150 countries and regions globally.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Seamaty designs, manufactures, and markets point-of-care testing (POCT) medical and veterinary diagnostic instruments and reagent consumables. The company sells five major POCT product lines (microfluidic biochemistry, blood gas electrolyte, chemiluminescence immunoassay, blood cell analysis, and PCR molecular detection) along with single-use reagent discs that contain freeze-dried reagents for routine biochemistry, electrolytes, coagulation, blood gas, and inflammation marker testing. Products are sold both directly through 8 overseas subsidiaries and via a global distributor network to veterinary clinics, pet hospitals, primary healthcare institutions, and aquaculture operations.

Product overview

Seamaty offers a comprehensive POCT (Point-of-Care Testing) product portfolio centered on biochemical analysis technology, consisting of both instruments and配套 reagent discs. The instrument lineup includes SD1 and SD2 dry biochemical analyzers for medical use, SMT-120VP/SMT-120Pro multi-functional biochemical analyzers for veterinary use, SG1 blood gas electrolyte analyzer, VG2 veterinary blood gas immunoanalyzer, MiniLabVet four-channel analyzer, and VQ1 nucleic acid detection system. The reagent disc portfolio features 39-40 test items across multiple combinations for both medical and veterinary applications including liver/kidney function, coagulation, blood gas, inflammation markers, and specialty testing. Products integrate microfluidic technology for platform miniaturization and automation, achieving 12-minute test turnaround with minimal sample requirements.

Differentiator

Problem solved

Functional benefit

Products and services

• SD1 Fully Automatic Dry Biochemical Analyzer (全自动干式生化分析仪SD1) Portable fully automatic dry biochemical analyzer for medical diagnosis. Detects electrolytes and routine liver/kidney/cardiac/glycolipid biochemical items with reference laboratory precision. Uses internet+medical and cloud technology for remote result interpretation. Features intelligent portability, simple operation, high automation, minimal sample volume, accurate testing, and maintenance-free design. Used by grassroots medical institutions, clinics, emergency departments, and ICUs.
• SMT-120VP Veterinary Automatic Biochemical Analyzer (SMT-120VP兽用全自动生化分析仪) Multi-functional fully automatic veterinary biochemical analyzer using microfluidic technology for platform miniaturization and automation. Features IRQC intelligent quality control system. Tests include routine biochemistry, coagulation, blood gas electrolytes, and canine/feline inflammation markers (c-CRP, f-SAA). Used by veterinary clinics, pet hospitals, fish farms, and veterinary schools globally.
• SMT-120Pro Fully Automatic Biochemical Analyzer (全自动生化分析仪SMT-120Pro) POCT biochemical analyzer integrating biochemistry, coagulation, CRP, and electrolyte testing for medical use, with microfluidic platform technology.
• SD2 Fully Automatic Microfluidic Dry Biochemical Analyzer (全自动微流控干式生化分析仪SD2) POCT dry biochemical analyzer integrating routine biochemistry, electrolytes, and coagulation detection. Combines microfluidic technology with precision testing capabilities.
• SG1 Blood Gas Electrolyte Analyzer (血气电解质分析仪SG1) Blood gas electrolyte analyzer using dry electrochemical method combined with microfluidic technology for blood electrolyte and blood gas monitoring. Compact handheld/portable design.
• VG2 Veterinary Blood Gas Immunoanalyzer (兽用血气免疫分析仪VG2) Veterinary blood gas immunoanalyzer combining fluorescent immunoassay and blood gas electrolyte platforms. Can detect up to 27 immunoassay items and 17 blood gas electrolyte parameters.
• MiniLabVet Veterinary Four-Channel Analyzer (MiniLabVet兽用四通道分析仪) Veterinary four-channel micro-laboratory integrating biochemistry, fluorescent immunoassay, and blood gas electrolyte three technology platforms with multi-dimensional expansion and precise detection capabilities. Used by exotic animal clinics such as Shanghai Guagua Pet Hospital.
• Qt3 Veterinary Automatic Biochemical Analyzer (Qt3兽用全自动生化分析仪) Veterinary automatic biochemical analyzer with new design, compatible with both circular and fan-shaped reagent discs for precise and reliable results.
• V7 Veterinary Automatic Biochemical Analyzer (V7兽用全自动生化分析仪) Veterinary automatic biochemical analyzer using microfluidic technology and freeze-drying process, offering up to 41 test items.
• VQ1 Fully Integrated Nucleic Acid Detection System / Veterinary PCR Instrument (VQ1全自动一体式核酸检测系统) Fully integrated nucleic acid detection system / veterinary PCR instrument for animal molecular diagnostics.
• SMT-680 High-Throughput POCT Chemiluminescence Immunoassay Analyzer (SMT-680高通量POCT化学发光免疫分析仪) High-throughput POCT chemiluminescence immunoassay analyzer combining large-scale chemiluminescence advantages (high throughput, high precision, low cost) with POCT equipment benefits (portable, easy to use, maintenance-free). Uses world's first capillary chemiluminescence detection platform.
• Medical Biochemical Diagnostic Reagent Discs (医用生化诊断试剂盘) Biochemical diagnostic reagent discs using microfluidic technology for highly integrated sample processing. Contains 40 test items with 39 reagent disc combinations, completing testing within 12 minutes. Used as consumables with Seamaty medical analyzers.
• Animal Biochemical Reagent Discs (动物生化试剂盘) Veterinary biochemical diagnostic reagent discs with 39 test items and 13 reagent disc combinations. Single disc can test up to 24 items. Includes panels for health check, liver function, kidney function, pre-surgical testing, coagulation, canine/feline inflammation, and exotic animal testing.

Named customers16 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Partnerships

Eight partnerships are on record, tiered minor and core.

• SubotizminorGTM or Marketing Partner · 1 January 2026Co-hosted side event at CES 2026 exploring AI product deployment and commercialization challenges in Southeast Asian markets.
• Sichuan University (四川大学)coreStrategic or Co-development Partner · 19 November 20245 million yuan research collaboration for joint development of high-performance biosensors. Partnership between Seamaty's chairman Ran Peng and Professor Xiao Dan's bio-sensing research team. Includes talent cultivation, academic exchange, and technology transfer cooperation.
• Singapore SPCAcoreStrategic or Co-development PartnerCorporate social responsibility partnership providing free diagnostic equipment donations to support non-profit community animal clinic serving stray animals and animal welfare organizations.
• Southeast Asian Veterinary DelegationcoreStrategic or Co-development PartnerPost-WSAVA 2024 collaboration with veterinary professionals from Southeast Asia. Includes company visits, strategic discussions, and partnership strengthening activities at Chengdu headquarters.
• Dokuz Eylul University Veterinary Faculty (Turkey)coreStrategic or Co-development PartnerEquipment donation agreement with veterinary school in Izmir for teaching and research purposes. Device suitable for laboratory research and wildlife rescue operations.
• Jilin Agricultural University (China)minorStrategic or Co-development Partner3 SMT-120V analyzers donated to support veterinary medicine discipline development and teaching at animal science and veterinary colleges.
• Mahasarakham University (Thailand)coreStrategic or Co-development PartnerStrategic cooperation providing veterinary teaching facilities for animal medical laboratory testing. Supports培养更多全面技能型兽医人才.
• WSAVA (World Small Animal Veterinary Association)coreGTM or Marketing PartnerParticipation in WSAVA 2024 World Congress for small animal veterinary professionals, showcasing products and building international partnerships.

Scale indicators22 records

Recent moves27 records

Expansion highlights6 records

Direct peers

• Edan Instruments: Shenzhen-based medical equipment manufacturer with veterinary and human POCT portfolios spanning chemistry, blood gas, and ultrasound. Closely comparable mid-tier Chinese diagnostics competitor with overlapping export markets.
• IDEXX Laboratories: Global leader in veterinary diagnostics and reference laboratory services with point-of-care analyzers (Catalyst Dx, ProCyte Dx) widely deployed in companion animal clinics. Directly comparable to Seamaty's veterinary POCT biochemistry, blood gas, and immunoassay offerings.
• Sinocare: Chinese diagnostics company focused on POCT blood glucose, HbA1c, and chemistry analyzers for clinical and consumer markets. Competes in adjacent point-of-care testing categories with similar Chinese OEM/export distribution model.
• Mindray: Shenzhen-based global medical device manufacturer with veterinary and human diagnostic product lines including chemiluminescence, hematology, and chemistry analyzers. Competes with Seamaty in Chinese hospitals and emerging-market veterinary channels.
• Heska Corporation (Antech Diagnostics / Mars Petcare): Veterinary point-of-care diagnostics specialist now part of Antech Diagnostics (owned by Mars Petcare), offering chemistry, hematology, and immunoassay analyzers for small animal practices. Direct competitor in the veterinary POCT segment.

Emerging players

• OPTI Medical Systems: Specialized blood gas and electrolyte analyzer manufacturer serving hospital point-of-care and veterinary reference lab markets. Comparable as a niche POCT vendor competing for share against Seamaty's SG1 blood gas line.

Broad incumbents

• Zoetis: World's largest animal health company with a diagnostics division (Vetscan) offering point-of-care chemistry, hematology, and rapid immunoassay analyzers for vet clinics. Broad incumbent overlapping with Seamaty's veterinary POCT portfolio at significantly larger scale.
• Nova Biomedical: Specialized POCT manufacturer best known for Stat Profile series blood gas/critical care analyzers and chemical analyzers used in hospital and research settings. Direct overlap with Seamaty's blood gas electrolyte and POCT chemistry lines.
• Abbott Point of Care: Major medical device incumbent with the i-STAT system, the dominant handheld blood gas/chemistry analyzer used across hospitals globally, and the Piccolo Xpress clinical chemistry analyzer. Overlaps with Seamaty's human medical POCT blood gas and chemistry product line.

Regional players

• Woodley Equipment Company: UK-based veterinary diagnostic equipment distributor supplying chemistry, hematology, and immunoassay analyzers to small animal practices across the UK and Ireland. Comparable as a regional vet POCT equipment specialist competing for veterinary account share outside Seamaty's subsidiary footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/seamaty

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries9 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Seamaty